MyHHR News Locations
EN | FR
Practices
People
Careers
Associate Recruiting Working At HHR Available Positions
Culture
About Us Diversity Pro Bono
Practices
People
Careers
Associate Recruiting Working At HHR Available Positions
Culture
About Us Diversity Pro Bono
MyHHR News Locations
EN | FR
Practices
People
News
View All Results >

Life Sciences

Hughes Hubbard & Reed LLP • A New York Limited Liability Partnership

One Battery Park Plaza • New York, New York 10004-1482 • +1 (212) 837-6000

Attorney advertising. Readers are advised that prior results do not guarantee a similar outcome. No aspect of this advertisement has been approved by the Supreme Court of New Jersey. For information regarding the selection process of awards, please visit https://www.hugheshubbard.com/legal-notices-methodologies.

 
Saved To MyHHR

“Life Sciences”

General Folder

View MyHHR
Share/Print
Email Print
   
Overview
People
Client Advisories
News

Pharmaceutical, biotechnology and healthcare companies face a complex array of issues and require multi-skilled legal teams that serve as true partners to their business. Our lawyers have a comprehensive understanding of our clients’ challenges, opportunities and goals and provide sophisticated and precise guidance across a complete spectrum of legal services. 

Mergers and acquisitions, joint ventures, corporate transactions and licensing:

  • Pharmaceutical companies entering or expanding their presence in the US, Europe, Latin America and the Pacific Basin
  • Issues involving licensed pharmaceutical products, biologics and intellectual property
  • Joint ventures and strategic alliances, specifically including licensing, product development, research and marketing collaborations
  • Transactions involving international performance and regulatory clearances
  • Creation of novel product sourcing and distribution agreements
  • Negotiating and implementing agreements with contracts research organizations


Antitrust:

  • Private antitrust litigation
  • Criminal grand jury inquiries
  • Civil governmental inquiries
  • All phases of Hart-Scott Rodino
  • Post-closing antitrust reviews of collaborations between competitors
  • Antitrust issues attendant to product development, marketing and compliance
  • Development and implementation of corporate compliance programs
  • Advice regarding EU competition rules in both our domestic and Paris offices
  • Competition law and enforcement in the Pacific Basin, South America, and Africa


Litigation, arbitration and dispute resolution:

  • Massive product liability litigation
  • Insurance coverage disputes
  • General civil litigation
  • Corporate reorganization and bankruptcy cases
  • Alternative dispute resolution
  • Pharmaceutical licensing agreements
  • Patent infringement and validity lawsuits for medical and dental device companies
  • False advertising claims under the Lanham Act


Food and drug law: 

  • Representation of multinational research-based pharmaceutical companies
  • Representation of foreign and domestic medical device and cosmetics manufacturers
  • US Food and Drug Administration regulatory matters


US employment law:

  • Development and review of compliance programs
  • Defense in discrimination, wrongful termination and breach of contract cases
  • Employment agreements
  • Negotiation of collective bargaining agreements with local unions 


Government contracts law:

  • Bid protests
  • Post-award audits
  • Enforcement actions
  • Practice before the executive agencies, the General Services Administration, the boards of contract appeals and federal courts
  • Federal Supply Schedule contracting under the Veterans Healthcare Act of 1992
Photo of 		Patrice Jean

Patrice Jean

Chair

Photo of 		Patrice Jean

Patrice Jean

Chair

Photo of 		James E. Berger

James E. Berger

Partner

Photo of 		Charles W. Cohen

Charles W. Cohen

Partner

Photo of James W. Dabney

James W. Dabney

Retired Partner

Photo of Christophe Fichet

Christophe Fichet

Partner

Photo of James C. Fitzpatrick

James C. Fitzpatrick

Partner

Photo of Remy Gerbay

Remy Gerbay

Partner

Photo of 		Theodore V.H. Mayer

Theodore V.H. Mayer

Partner

Photo of Robb W. Patryk

Robb W. Patryk

Partner

Photo of Laura N. Perkins

Laura N. Perkins

Partner

Photo of Elizabeth Solander

Elizabeth Solander

Partner

Photo of Daniel H. Weiner

Daniel H. Weiner

Partner

Photo of 		David M. Woods

David M. Woods

Partner

Photo of Emma L. Baratta

Emma L. Baratta

Counsel

Photo of Mary E. Bartkus

Mary E. Bartkus

Special Counsel

Photo of Christian Belloin

Christian Belloin

Senior Counsel

Photo of Steven Sheppard DiCesare

Steven Sheppard DiCesare

Counsel

Photo of John F. Duffy

John F. Duffy

Of Counsel

Photo of 		Brendan T. Franzoni

Brendan T. Franzoni

Counsel

Photo of James R. Klaiber

James R. Klaiber

Counsel

Photo of 		James B. Kobak, Jr.

James B. Kobak, Jr.

Senior Ethics Counsel

Photo of Peter Langenberg

Peter Langenberg

Senior Counsel

Photo of 		Tina M. Schaefer

Tina M. Schaefer

Counsel

Photo of 		Kevin E. Braker

Kevin E. Braker

Associate

Photo of Adrien Morisse

Adrien Morisse

Associate

Photo of Lynn M. Russo

Lynn M. Russo

Associate

Photo of Matthew Strobbe

Matthew Strobbe

Associate

Photo of Sara Gorjestani

Sara Gorjestani

Medical Research Analyst

Photo of Sally Merriam

Sally Merriam

Managing Analyst

Medical Device Approval and Regulation in the United States
Client Advisories
View News Article
Expedited Antitrust Review of Proposals for Health and Safety Collaborative Efforts to Combat COVID-19
Client Advisories
View News Article
COVID-19 Impact on Clinical Research and New FDA Guidance
Client Advisories
View News Article
New FDA Guidance on Medical Devices
Client Advisories
View News Article
Chair of HHR’s Litigation Department Dan Weiner Featured in The American Lawyer’s Litigation Leaders Q&A
Articles & Press |
People
View News Article
Amina Hassan and Jim Kobak Appointed to Two Law360 Advisory Boards
News & Events |
People
View News Article
Firm Guides ANI Pharmaceuticals in Deal to Buy Novitium Pharma
News & Events
View News Article
Firm Helps Sellas Defeat Investors’ Securities Fraud Suit
News & Events
View News Article
In SSRN: Dispute Resolution Provisions in Life Sciences Agreements
Articles & Press
View News Article
Hughes Hubbard Helps Merck Obtain Significant Win in Supreme Court
News & Events |
Deals & Matters
View News Article
Litigation Wrap: Fourth Quarter 2017
News & Events |
Awards |
Deals & Matters |
People
View News Article
Seufert v. Merck and Cerveny v. Aventis: The Intersection of Science
Articles & Press
View News Article
Complex Product Liability Questions for Complex Large-Molecule Biologics
Articles & Press
View News Article
Renal Advantage Appeal Win in Overtime Case
News & Events |
Deals & Matters
View News Article
Hughes Hubbard Reps Epic Pharma in $550M Sale to Humanwell, PuraCap
News & Events |
Deals & Matters
View News Article
First Circuit Victory Secured for Pfizer in Diet Drug Case
News & Events |
Deals & Matters
View News Article
Hughes Hubbard Product Liability & Toxic Torts Spring Alert
News & Events
View News Article
Hughes Hubbard Paves Path for Clinquest Sale
News & Events |
Deals & Matters
View News Article
Firm Helps Magnisense Raise 5.5M Euros for Cardiovascular Tests
News & Events |
Deals & Matters
View News Article
Firm Advises Pharming in Financing Agreement
News & Events |
Deals & Matters
View News Article
Firm Helps Chiltern Buy Drug Research Company
News & Events |
Deals & Matters
View News Article
Hughes Hubbard Advises India’s Cipla in $550M Deal for 2 US Firms
News & Events |
Deals & Matters
View News Article
Hughes Hubbard Wins Summary Judgment in Wrongful Death Suit Against NYBC
News & Events |
Deals & Matters
View News Article
Firm Wins Fourth Circuit Appeal in 'Pill Mill' Case
News & Events |
Deals & Matters
View News Article
Hughes Hubbard Advises Merck in $9.5B Deal to Buy Cubist
News & Events |
Deals & Matters
View News Article
Hughes Hubbard Wins Jury Verdict for Pfizer in Fen-Phen Case
News & Events |
Deals & Matters
View News Article
Firm Wins Appeal for Merck in Licensing Spat
News & Events |
Deals & Matters
View News Article
Hughes Hubbard Advises Merck in $3.85B Purchase of Idenix
News & Events |
Deals & Matters
View News Article
Hughes Hubbard Wins Coverage for Pharma Distributor
News & Events |
Deals & Matters
View News Article
Renal Advantage Wins Denial of Dietitian Class Certification
News & Events |
Deals & Matters
View News Article
Hughes Hubbard Helps Pfizer Derail Fen-Phen Suit
News & Events |
Deals & Matters
View News Article
Merck Sells 50% Interest in Joint Venture With Johnson & Johnson
News & Events |
Deals & Matters
View News Article
Stage-Setting For Circ Split: Generic Drug Preemption?
Articles & Press
View News Article
New California Appellate Decision Makes Brand Name Drug Manufacturers Potentially Liable for Injuries Suffered by Consumers of Generic Drugs
Articles & Press
View News Article
Expedited Antitrust Review of Proposals for Health and Safety Collaborative Efforts to Combat COVID-19 View News Article
COVID-19 Impact on Clinical Research and New FDA Guidance View News Article
Hughes Hubbard Helps Merck Obtain Significant Win in Supreme Court View News Article
Related Areas of Focus
Antitrust & Competition
Mergers & Acquisitions
Intellectual Property & Technology
Product Liability
Regulatory Compliance
White Collar & Regulatory Defense

Hughes Hubbard & Reed LLP

Copyright 2023


Legal Notices & Methodologies Attorney Advertising Sitemap
  • Locations
  • New York City
  • Kansas City
  • Los Angeles
  • Miami
  • Paris
  • Rio de Janeiro*
  • Tokyo
  • Washington, D.C.

*In cooperation with Saud Advogados

Privacy Policies and Notices

Careers
Associate Recruiting Working At HHR Available Positions
Culture
About Us Diversity Pro Bono
Contact